ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimi... ( FREDERICK Md. April 1 2008 /- ImQ...)

ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones

Date:4/1/2008

FREDERICK, Md., April 1, 2008 /PRNewswire/ -- ImQuest BioSciences, Inc. announced today the publication of the results of an important structure- activity relationship study to investigate the efficacy and toxicity of a series of pyrimidinedione analogs against HIV-1 and HIV-2. The manuscript, published in the journal Antiviral Chemistry and Chemotherapy, shows the results of ImQuest's HIV drug development program based on compounds which it licensed from Samjin Pharmaceutical Co. Ltd. The report, authored by Robert W. Buckheit, Jr., Ph.D. (Executive Vice President and Chief Scientific Officer of ImQuest) describes the synthesis of the highly potent pyrimidinedione series and the structural features of the compounds which are responsible for their high level of potency against HIV, the expanded range of action to include HIV-2, and the unique dual mechanism of entry and RT inhibitory activity against HIV-1.

"The studies performed will allow us to focus our resources on the preclinical and clinical development of the most potent lead pyrimidinedione and to gain insight into the molecular features of the compounds which yield the high potency and characteristic dual mechanism of antiviral action of these unique compounds," explained Dr. Buckheit. Other coauthors on this paper include ImQuest virologists Tracy Hartman, Karen Watson and Lu Yang and Samjin chemists Ho-Seok Kwon, Sun-Hwan Lee, Jae-Woong Lee, Dong-Wook Kang, Sun-Gan Chung and Eui-Hwan Cho.

ImQuest expects to submit an IND to initiate Phase 1 human clinical trials with IQP-0410, a highly potent member of the pyrimidinedione series in the third quarter of 2008. In addition, ImQuest has initiated IND-enabling studies with the pyrimidinedione IQP-0528 as a potential anti-HIV topical microbicide.

ImQuest Life Sciences, a privately held U.S. company located in Frederick, Maryland specializes in early stage drug development of novel compounds for the treatment of infectious disease and
'/>"/>

SOURCE ImQuest BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
3. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
4. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
5. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
6. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
9. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Tapestry Reports Second Quarter 2007 Results

Post Your Comments:

(Date:8/18/2008)...O, Aug. 18 /- The next time you consi...ff, it might be worth counting sheep,instead. A se...er in San,Diego, Calif. has found evidence that ta...k of skin cancer., Daniel F. Kripke, M.D.,s artic...eeping pills and cancer, has just been published i...

(Date:8/18/2008)...iates Clinical Trials Phase of Test Development Pr...-FirstCall/ -- Beckman,Coulter, Inc. (NYSE: BEC )...y out its U.S. royalty obligation to Nephromics LL... women,s health. The license is for tests,related ...f preeclampsia, a,leading cause of maternal death....

(Date:8/17/2008)...Australia, Aug. 17 /Xinhua-...ed that the first pivotal Phase 3,clinical trial o...has,completed enrolment., The first efficacy data... the first half of 2009. The trial commenced its d...ruitment target of 250 subjects in June,2008 and c...

(Date:8/14/2008)...N, N.J., Aug. 14 /- Pharmas...aceutical company committed to,discovering, develo...l,infections, reported unaudited financial results... Pharmasset reported a net loss attributable to,co...share of $0.69 for the,quarter ended June 30, 2008...

[1] Prescription Sleeping Pill Use Tied to Cancer [0] Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers [1] Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment [0] Pharmasset Reports Financial Results for Quarter Ended June 30, 2008

...NCISCO--(BUSINESS WIRE)--May 21, 2007 - Gilead Sci...of two long-term studies,evaluating ambrisentan, a...ERA) for the treatment of patients with pulmonary,...are from patients,who originally participated in t..., a Phase II study of patients who had,previously ...

... product recently approved by FDA for long-term,ma...ata demonstrate,first nebulized formoterol fumarat...y powder formoterol, enhanced patient quality of,l...y 20, 2007) – Data presented at the,Internat...(ATS),demonstrate that Perforomist™ (formote...

Other Medicine Technology:Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7

Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...shed yesterday looks into support props for care g... elucidates the plight of most relatives // and ca...ften the rehabilitation and restoration of confide... realms of hospital in –patient care. It is the v...

...sions for breast cancer fell by a third between 19...ncy for Healthcare Research and Quality. The decli...cilities for breast cancer surgeries, plus the gro...ns such as lumpectomies, which are typically perfo...

...survivors will be able to do away with invasive br...ch involving stem cells //extracted from their own... who are investigating the potential these cells m.... In animal models, the researchers hope to prove...

...hyam Sarda, a prime accused in the expired blood t...nior police official.// "We have arrested Ghanshy...uced in court," said Gyanwant Singh, deputy commis... department). Ghanshyam's brother, Govind Sarda,...

Other Medicine News:Health News:Breast reconstruction may be possible with fat stem cells 2

Support to care takers of psychiatric patients in pieces?Fewer Women Having Inpatient Breast Cancer Surgery Breast reconstruction may be possible with fat stem cells Accused Arrested in Blood Test Kit Scam

.../Cuff combines the therapeutic benefits of control...ing, and cold to minimize pain. The cuff is anatom...ing maximum cryotherapy. The Elbow Cryo/Cuff is av...c size.,All Cryo/Cuffs can be ordered as a single ...

...; ROM Elbow Orthosis features aluminum cuffs that ...r joint alignment, unique slot/screw adjustment me...l adjustments to cuff position. Cuffs are configur...with contractures.,The hinge can be locked in any...

...CTION Elbow Wrap replaces messy taping and bulky e...s experiencing epicondylitis. Preferred by doctors...y fit. Two overlay straps allow you to apply force...lds the Elbow Wrap comfortably in place. Available...

The Bledsoe Original Arm Brace is designed to handle post-op elbow arthroscopy, severe elbow strains and ligament trauma. The Bledsoe Extender Arm Brace should be used when limited R.O.M. or locked c

Medicine Products:

Elbow Cryo/Cuff™QualCare™ ROM Elbow Orthosis ACTION™ Elbow Wrap Bledsoe Original Arm Brace

ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimi...( FREDERICK Md. April 1 2008 /- ImQ...),Health